D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 133 SEK -3.62% Market Closed
Market Cap: 2.2B SEK
Have any thoughts about
Devyser Diagnostics AB?
Write Note

Devyser Diagnostics AB
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Devyser Diagnostics AB
Accounts Payable Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
D
Devyser Diagnostics AB
STO:DVYSR
Accounts Payable
kr14.2m
CAGR 3-Years
31%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Accounts Payable
kr49.3m
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Accounts Payable
kr10.4m
CAGR 3-Years
-10%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Accounts Payable
kr190m
CAGR 3-Years
62%
CAGR 5-Years
36%
CAGR 10-Years
26%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Accounts Payable
kr1.4B
CAGR 3-Years
20%
CAGR 5-Years
32%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Accounts Payable
kr29.9m
CAGR 3-Years
28%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Devyser Diagnostics AB's Accounts Payable?
Accounts Payable
14.2m SEK

Based on the financial report for Dec 31, 2023, Devyser Diagnostics AB's Accounts Payable amounts to 14.2m SEK.

What is Devyser Diagnostics AB's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
35%

Over the last year, the Accounts Payable growth was 48%. The average annual Accounts Payable growth rates for Devyser Diagnostics AB have been 31% over the past three years , 35% over the past five years .

Back to Top